We had a sizzling time at the ADCES National Diabetes Meeting—connecting with new colleagues and joyfully reuniting with old friends. I wore a special white suit inherited from my husband’s … Continue reading We Had a Sizzling Time at ADCES in Phoenix
MJ is a 56-year-old with type 2 diabetes (A1C 7.3%), HTN, and dyslipidemia. Current medications include metformin 1,000 mg twice daily, lisinopril, and atorvastatin. Activity includes walking 20–30 minutes most … Continue reading Question of the Week | Time Restricted Eating – Best Approach
Featured Articles ___________________________ Sizzling ADCES Highlights Strategies Across CKM Syndrome Stages Tandem Turns Up the Tech for t:slim X2 and Mobi Question of the Week Rationale of the Week Upcoming … Continue reading September 2025 eNews
For last week’s practice question, we quizzed participants on Diabetes Distraction in the Clinic. 97% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Diabetes Distraction in the Clinic
PJ has had type 2 diabetes for 8 years and is here for a follow-up visit. Labs indicate A1c at 7.2%, lipids at target, eGFR of 78 mL/min/1.73m², and urine … Continue reading Question of the Week | Lifestyle Therapy for MASLD and MASH
By: Beverly Thomassian GLP-1 receptor agonists and GLP-1/GIP combination therapies have become foundational treatments for type 2 diabetes and obesity. Their benefits now extend well beyond glycemic control and weight … Continue reading Indications for GLP-1/GIP RA Summary Sheet and Beyond!
AJ is a 52-year-old with type 2 diabetes presents with worsening hyperglycemia despite taking three diabetes medications. AJ says, “No matter what I do, I can’t seem to get my … Continue reading Question of the Week | Clinical Clues to Hypercortisolism
By: Astraea Ballinger and Beverly Thomassian Hormone Replacement Therapy (HRT) is an important topic of conversation due to its vast untapped benefits for women and people with uteruses. Due to … Continue reading Hormone Replacement Therapy Warnings Removed